Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial ribosomal protein L30 pseudogene refers to genomic DNA sequences that are highly similar to the functional MRPL30 gene, which encodes a component of the 39S large subunit of the mammalian mitochondrial ribosome. These pseudogenes result from duplication or retrotransposition events and do not encode functional protein products. In the human genome, several MRPL30 pseudogenes exist, and they serve primarily as molecular fossils rather than as active participants in ribosomal function or disease. They do not have known biological, pathological, or therapeutic significance, but they can be used as markers for evolutionary and genomic studies.
No drug mechanism of action applies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L30 pseudogene (MRPL30P).